KNE fundamentals
An in-depth look to KANE BIOTECH INC operating, investing, and financing activities
KNE free cash flow for Q1 24 is -989.25 k CAD. For 2023, KNE free cash flow was -2.09 M CAD and operating cash flow was -2.08 M CAD.
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CAD
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q1 '24
TTM